TY - JOUR
T1 - Expanding the clinical phenotype in patients with disease causing variants associated with atypical Usher syndrome
AU - Igelman, Austin D.
AU - Ku, Cristy
AU - da Palma, Mariana Matioli
AU - Georgiou, Michalis
AU - Schiff, Elena R.
AU - Lam, Byron L.
AU - Sankila, Eeva Marja
AU - Ahn, Jeeyun
AU - Pyers, Lindsey
AU - Vincent, Ajoy
AU - Ferraz Sallum, Juliana Maria
AU - Zein, Wadih M.
AU - Oh, Jin Kyun
AU - Maldonado, Ramiro S.
AU - Ryu, Joseph
AU - Tsang, Stephen H.
AU - Gorin, Michael B.
AU - Webster, Andrew R.
AU - Michaelides, Michel
AU - Yang, Paul
AU - Pennesi, Mark E.
N1 - Funding Information:
This work is funded by the National Institutes of Health [P30EY010572, K08EY026650, 5P30CA013696, U01EY030580, U54OD020351, R24EY028758, R01EY009076, R24EY027285, 5P30EY019007, R01EY018213, R01EY024698, R01EY024091, R01EY026682, R21AG050437NIH intramural research fund], the Research to Prevent Blindness [unrestricted grant for Casey Eye Institute, unrestricted grant for UCLA], the Foundation Fighting Blindness [CD-NMT-0714–0648, CD-CL-0617-0727-HSC], New York Regional Research Center Grant [PPA-1218-0751-COLU], Jonas Children’s Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory, the Schneeweiss Stem Cell Fund, New York State [SDHDOH01-C32590GG-3450000], Nancy & Kobi Karp, the Crowley Family Funds, the Rosenbaum Family Foundation, Alcon Research Institute, and the Gebroe Family Foundation, Harold and Pauline Price Foundation, Nina Abrams Fund, ames V. Bastek, M.D. Hereditary Retinal Disease Research Program, the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001, and the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The sponsors or funding organizations had no role in the design or conduct of this research; Alcon Research Institute; CAPES [Finance Code 001]; Foundation Fighting Blindness [CD-CL-0617-0727-HSC,CD-NMT-0714–0648]; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; Crowley Family Funds; Nina Abrams Fund; Harold and Pauline Price Foundation; Gebroe Family Foundation; Nancy & Kobi Karp;Schneeweiss Stem Cell Fund [SDHDOH01-C32590GG-3450000]; Jonas Children’s Vision Care and Bernard & Shirlee Brown Glaucoma Laboratory; James V. Bastek, M.D. Hereditary Retinal Disease Research Program; Rosenbaum Family Foundation; New York Regional Research Center Grant [PPA-1218-0751-COLU]; Research to Prevent Blindness [Unrestricted Grant for Casey Eye Institute,Unrestricted Grant for UCLA]. The authors would like to thank Delphine Blain, ScM, MBA - Certified Genetic Counselor for support with this project.
Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.
PY - 2021
Y1 - 2021
N2 - Atypical Usher syndrome (USH) is poorly defined with a broad clinical spectrum. Here, we characterize the clinical phenotype of disease caused by variants in CEP78, CEP250, ARSG, and ABHD12. Chart review evaluating demographic, clinical, imaging, and genetic findings of 19 patients from 18 families with a clinical diagnosis of retinal disease and confirmed disease-causing variants in CEP78, CEP250, ARSG, or ABHD12. CEP78-related disease included sensorineural hearing loss (SNHL) in 6/7 patients and demonstrated a broad phenotypic spectrum including: vascular attenuation, pallor of the optic disc, intraretinal pigment, retinal pigment epithelium mottling, areas of mid-peripheral hypo-autofluorescence, outer retinal atrophy, mild pigmentary changes in the macula, foveal hypo-autofluorescence, and granularity of the ellipsoid zone. Nonsense and frameshift variants in CEP250 showed mild retinal disease with progressive, non-congenital SNHL. ARSG variants resulted in a characteristic pericentral pattern of hypo-autofluorescence with one patient reporting non-congenital SNHL. ABHD12-related disease showed rod-cone dystrophy with macular involvement, early and severe decreased best corrected visual acuity, and non-congenital SNHL ranging from unreported to severe. This study serves to expand the clinical phenotypes of atypical USH. Given the variable findings, atypical USH should be considered in patients with peripheral and macular retinal disease even without the typical RP phenotype especially when SNHL is noted. Additionally, genetic screening may be useful in patients who have clinical symptoms and retinal findings even in the absence of known SNHL given the variability of atypical USH.
AB - Atypical Usher syndrome (USH) is poorly defined with a broad clinical spectrum. Here, we characterize the clinical phenotype of disease caused by variants in CEP78, CEP250, ARSG, and ABHD12. Chart review evaluating demographic, clinical, imaging, and genetic findings of 19 patients from 18 families with a clinical diagnosis of retinal disease and confirmed disease-causing variants in CEP78, CEP250, ARSG, or ABHD12. CEP78-related disease included sensorineural hearing loss (SNHL) in 6/7 patients and demonstrated a broad phenotypic spectrum including: vascular attenuation, pallor of the optic disc, intraretinal pigment, retinal pigment epithelium mottling, areas of mid-peripheral hypo-autofluorescence, outer retinal atrophy, mild pigmentary changes in the macula, foveal hypo-autofluorescence, and granularity of the ellipsoid zone. Nonsense and frameshift variants in CEP250 showed mild retinal disease with progressive, non-congenital SNHL. ARSG variants resulted in a characteristic pericentral pattern of hypo-autofluorescence with one patient reporting non-congenital SNHL. ABHD12-related disease showed rod-cone dystrophy with macular involvement, early and severe decreased best corrected visual acuity, and non-congenital SNHL ranging from unreported to severe. This study serves to expand the clinical phenotypes of atypical USH. Given the variable findings, atypical USH should be considered in patients with peripheral and macular retinal disease even without the typical RP phenotype especially when SNHL is noted. Additionally, genetic screening may be useful in patients who have clinical symptoms and retinal findings even in the absence of known SNHL given the variability of atypical USH.
KW - ABHD12
KW - ARSG
KW - Atypical usher syndrome
KW - CEP78
KW - cep250
UR - http://www.scopus.com/inward/record.url?scp=85109715696&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109715696&partnerID=8YFLogxK
U2 - 10.1080/13816810.2021.1946704
DO - 10.1080/13816810.2021.1946704
M3 - Article
C2 - 34223797
AN - SCOPUS:85109715696
SN - 0167-6784
VL - 42
SP - 664
EP - 673
JO - Ophthalmic Paediatrics and Genetics
JF - Ophthalmic Paediatrics and Genetics
IS - 6
ER -